Akoya Biosciences Inc (AKYA)
2.90
+0.11
(+3.94%)
USD |
NASDAQ |
May 16, 16:00
2.91
+0.01
(+0.34%)
After-Hours: 20:00
Akoya Biosciences Cash from Investing (Quarterly): -48.82M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -48.82M |
December 31, 2023 | -0.594M |
September 30, 2023 | -0.832M |
June 30, 2023 | -1.423M |
March 31, 2023 | 6.196M |
December 31, 2022 | 22.13M |
September 30, 2022 | 7.266M |
June 30, 2022 | -42.34M |
March 31, 2022 | -1.138M |
Date | Value |
---|---|
December 31, 2021 | -1.365M |
September 30, 2021 | -1.875M |
June 30, 2021 | -0.947M |
March 31, 2021 | -0.907M |
December 31, 2020 | 9.653M |
September 30, 2020 | -0.902M |
June 30, 2020 | -0.588M |
March 31, 2020 | -1.435M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-48.82M
Minimum
Mar 2024
22.13M
Maximum
Dec 2022
-3.407M
Average
-0.907M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
Bruker Corp | -304.20M |
Azenta Inc | -270.61M |
Harvard Bioscience Inc | -0.225M |
Bionano Genomics Inc | 47.59M |
Singular Genomics Systems Inc | 0.651M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.82M |
Cash from Financing (Quarterly) | -0.444M |
Free Cash Flow | -55.62M |
Free Cash Flow Per Share (Quarterly) | -0.4398 |
Free Cash Flow to Equity (Quarterly) | -21.85M |
Free Cash Flow to Firm (Quarterly) | -19.95M |
Free Cash Flow Yield | -40.71% |